Vimarsana
Biggest News Aggregation in the World

Page 47 - Eva Mathews News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Eva Mathews. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Eva Mathews Today - Breaking & Trending Today

GSK's RSV vaccine shows positive results in adults aged 50-59 - Vimarsana News

GSK's RSV vaccine shows positive results in adults aged 50-59

The British drugmaker's shot, called Arexvy, met the primary goal in the Phase-III trial of eliciting an immune response in adults of the reported age group who are at an increased risk of catching the virus due to certain underlying medical conditions, the company said on Wednesday. RSV typically causes cold-like symptoms, but is a leading cause of pneumonia in toddlers and the elderly.

Source: yahoo.com
GSK's common respiratory virus vaccine shows potential in adults aged 50-59 | WKZO | Everything Kalamazoo - Vimarsana News

GSK's common respiratory virus vaccine shows potential in adults aged 50-59 | WKZO | Everything Kalamazoo

(Reuters) -GSK said its vaccine for respiratory syncytial virus (RSV) showed positive preliminary results in a late-stage trial to protect adults aged...

Source: wkzo.com
GSK's common respiratory virus vaccine shows potential in adults aged 50-59 - Vimarsana News

GSK's common respiratory virus vaccine shows potential in adults aged 50-59

GSK said its vaccine for respiratory syncytial virus showed positive preliminary results in a late-stage trial to protect adults aged 50 to 59 from the disease that causes thousands of...

UK extends deadline on in-depth probe into Adobe's $20 billion deal for Figma | WKZO | Everything Kalamazoo - Vimarsana News

UK extends deadline on in-depth probe into Adobe's $20 billion deal for Figma | WKZO | Everything Kalamazoo

(Reuters) - Britain's competition regulator, on Wednesday, extended by eight weeks the deadline to complete its in-depth probe into Photoshop owner Ad...

Source: wkzo.com
GSK's common respiratory virus vaccine shows potential in adults aged 50-59 - Vimarsana News

GSK's common respiratory virus vaccine shows potential in adults aged 50-59

(Reuters) -GSK said its vaccine for respiratory syncytial virus (RSV) showed positive preliminary results in a late-stage trial to protect adults aged...

Source: whbl.com